Nutanix improves financials with robust strategies against VMware, offering cost efficiencies. Strong margins ahead, but high ...

In the closing of the recent trading day, Nutanix (NTNX) stood at $70.28, denoting a -1.83% change from the preceding trading day.

Nutanix offers healthcare organizations a streamlined, scalable path to adopting GenAI technologies with Nutanix Enterprise ...

Analyst evaluates Nutanix's growth prospects, cost pressures, and stock valuation in light of earnings growth and industry ...

Nutanix has a 52-week low of $43.35 and a 52-week high of $75.80. Insiders Place Their Bets In other news, CFO Rukmini Sivaraman sold 11,810 shares of the stock in a transaction that occurred on ...

Rapid GenAI application adoption drives new era of application, infrastructure modernisationA Nutanix study reveals that GenAI is changing organisations' priorities, with security and privacy being a ...

We’re spending more time analyzing the back end of AI in terms of the models being built and the IT services being used to run it, rather than the use cases itself.

Chicago Partners Investment Group LLC bought a new position in shares of Nutanix, Inc. (NASDAQ:NTNX – Free Report) in the ...